2009Unpublished venueRequires access

EFECT OF ATORVASTATIN ON MCP-1 IN RATS WITH DIABETIC NEPHROPATHY

Zhao Wang

Open publisher page 0 citations

Abstract

Objective:To explore the protective mechanism of Atorvastatin on kidneys indiabetic rats by investigating the effects of Atorvastatin on MCP-1 in rats with diabetic nephropathy.Methods:A total of 24 male SD rats induced by streptozocin were randomly divided into 3 groups,normol control,diabetes and dibetes treated by atorvastatin.24-hour urine protein were measured by automatic biochemistry analyzer and Expression of MCP-1 were detected by immunohistochemical staining.Results:24-hour urine protein in diabetic rats were significantly higher than those in normal rats (P0.01),Atorvastatin treatment significantly inhibited activation of MCP-1(P0.05),decreased urine protein excretion.Conclusion:Atorvastatin exerted protective effect on diabetic nephropathy,Which is probably one of the mechanisms that decreased the expression of MCP-1.

About this research paper

What this paper is about

Objective:To explore the protective mechanism of Atorvastatin on kidneys indiabetic rats by investigating the effects of Atorvastatin on MCP-1 in rats with diabetic nephropathy.Methods:A total of 24 male SD rats induced by streptozocin were randomly divided into 3 groups,normol control,diabetes and dibetes treated by atorvastatin.24-hour urine protein were measured by automatic biochemistry analyzer and Expression of MCP-1 were detected by immunohistochemical staining.Results:24-hour urine protein in diabetic rats were significantly higher than those in normal rats (P0.01),Atorvastatin treatment significantly inhibited activation of MCP-1(P0.05),decreased urine protein excretion.Conclusion:Atorvastatin exerted protective effect on diabetic nephropathy,Which is probably one of the mechanisms that decreased the expression of MCP-1.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To explore the protective mechanism of Atorvastatin on kidneys indiabetic rats by investigating the effects of Atorvastatin on MCP-1 in rats with diabetic nephropathy.Methods:A total of 24 male SD rats induced by streptozocin were randomly divided into 3 groups,normol control,diabetes and dibetes treated by atorvastatin.24-hour urine protein were measured by automatic biochemistry analyzer and Expression of MCP-1 were detected by immunohistochemical staining.Results:24-hour urine protein in diabetic rats were significantly higher than those in normal rats (P0.01),Atorvastatin treatment significantly inhibited activation of MCP-1(P0.05),decreased urine protein excretion.Conclusion:Atorvastatin exerted protective effect on diabetic nephropathy,Which is probably one of the mechanisms that decreased the expression of MCP-1.

Key concepts: Atorvastatin, Diabetic nephropathy, Streptozocin, Urine, Medicine, Endocrinology, Immunohistochemistry, Nephropathy

Related papers

Back to paper searchBrowse research topicsOriginal source
EFECT OF ATORVASTATIN ON MCP-1 IN RATS WITH DIABETIC NEPHROPATHY — Research Paper | ScholarLens